Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Stock

Showing results (201-210 of 546) with videos related to

Pageof 55
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1991
Sexual dimorphism of blood pressure: possible role of the renin-angiotensin systemJ Bachmann, M Feldmer, U Ganten, et al.
Journal of the Autonomic Nervous System|March 7, 1996
Relationship between rhythmic discharge patterns of neurons in the central nucleus of the amygdala, blood pressure fluctuations and cortical activityG Schulz, M Knuepfer, M Lambertz, et al.
Transplantation Proceedings|April 9, 1998
Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejectionS M Kang, Z Lin, N L Ascher, et al.
BJU International|July 10, 2007
Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or = 7 years of follow-upJamie A Cesaretti, Johnny Kao, Nelson N Stone, et al.
Experimental Neurology|September 1, 1987
Sensory input to single neurons in the amygdala of the catI Schütze, M M Knuepfer, A Eismann, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancerRyan J Burri, Nelson N Stone, Pam Unger, et al.
BJU International|May 11, 2012
Gleason 7 prostate cancer treated with low-dose-rate brachytherapy: lack of impact of primary Gleason pattern on biochemical failureRichard G Stock, Joshua Berkowitz, Seth R Blacksburg, et al.
Brachytherapy|November 3, 2009
Do high radiation doses in locally advanced prostate cancer patients treated with 103Pd implant plus external beam irradiation cause increased urinary, rectal, and sexual morbidity?Nelson N Stone, Jamie A Cesaretti, Barry Rosenstein, et al.
Urology|February 5, 2013
Long-term outcomes and toxicity in patients treated with brachytherapy for prostate adenocarcinoma younger than 60 years of age at treatment with minimum 10 years of follow-upMichael Buckstein, Todd J Carpenter, Nelson N Stone, et al.
BJU International|June 19, 2013
The relative importance of hormonal therapy and biological effective dose in optimizing prostate brachytherapy treatment outcomesRichard G Stock, Michael Buckstein, Jerry T Liu, et al.
Pageof 55

Showing results (201-210 of 546) with videos related to

Sort By:
Pageof 55
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1991
Sexual dimorphism of blood pressure: possible role of the renin-angiotensin systemJ Bachmann, M Feldmer, U Ganten, et al.
Journal of the Autonomic Nervous System|March 7, 1996
Relationship between rhythmic discharge patterns of neurons in the central nucleus of the amygdala, blood pressure fluctuations and cortical activityG Schulz, M Knuepfer, M Lambertz, et al.
Transplantation Proceedings|April 9, 1998
Fas ligand expression on islets as well as multiple cell lines results in accelerated neutrophilic rejectionS M Kang, Z Lin, N L Ascher, et al.
BJU International|July 10, 2007
Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or = 7 years of follow-upJamie A Cesaretti, Johnny Kao, Nelson N Stone, et al.
Experimental Neurology|September 1, 1987
Sensory input to single neurons in the amygdala of the catI Schütze, M M Knuepfer, A Eismann, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2010
Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancerRyan J Burri, Nelson N Stone, Pam Unger, et al.
BJU International|May 11, 2012
Gleason 7 prostate cancer treated with low-dose-rate brachytherapy: lack of impact of primary Gleason pattern on biochemical failureRichard G Stock, Joshua Berkowitz, Seth R Blacksburg, et al.
Brachytherapy|November 3, 2009
Do high radiation doses in locally advanced prostate cancer patients treated with 103Pd implant plus external beam irradiation cause increased urinary, rectal, and sexual morbidity?Nelson N Stone, Jamie A Cesaretti, Barry Rosenstein, et al.
Urology|February 5, 2013
Long-term outcomes and toxicity in patients treated with brachytherapy for prostate adenocarcinoma younger than 60 years of age at treatment with minimum 10 years of follow-upMichael Buckstein, Todd J Carpenter, Nelson N Stone, et al.
BJU International|June 19, 2013
The relative importance of hormonal therapy and biological effective dose in optimizing prostate brachytherapy treatment outcomesRichard G Stock, Michael Buckstein, Jerry T Liu, et al.
Pageof 55